Therapeutic strategies in psoriasis patients with psoriatic arthritis: focus on new agents.
about
Brodalumab for the Treatment of Psoriasis: A Review of Phase III TrialsIxekizumab for the Treatment of Psoriasis: A Review of Phase III TrialsThe role of p38 MAPK in the aetiopathogenesis of psoriasis and psoriatic arthritisTargeting of interleukin-17 in the treatment of psoriasisAnti-IL-17 phase II data for psoriasis: A review.Apremilast: first global approval.Proteomics focusing on immune markers in psoriatic arthritis.Apremilast: A Review in Psoriasis and Psoriatic Arthritis.Secukinumab: a promising therapeutic option in spondyloarthritis.PDE4 Inhibition and Inflammatory Bowel Disease: A Novel Therapeutic Avenue.Efficacy and Safety of Secukinumab in Elderly Subjects with Moderate to Severe Plaque Psoriasis: A Pooled Analysis of Phase III Studies.Comparison of US patient, rheumatologist, and dermatologist perceptions of psoriatic disease symptoms: results from the DISCONNECT study.Functional role of human interleukin-32 and nuclear transcription factor-kB in patients with psoriasis and psoriatic arthritis.
P2860
Q26746100-952B558A-9B8B-4EC7-9467-BD3F3B874CB8Q26766567-A0FFF132-3E42-4795-A4EA-2692AA74FD9FQ26821943-247B1EEC-F9C1-4237-B68A-00FBF66DEC66Q27026324-AB27F052-5712-48B3-B8E2-8BD5FC566375Q30760301-E7CD1EF2-6671-47E5-850E-2C97EE5E030CQ38209439-A45BA86F-6892-4A91-B836-DF8AF3F2B749Q38230695-BDF21028-34E1-4524-8436-8F72DCF24D6EQ38556637-5FDEB564-06E4-4D8D-AF1A-20C4F06EF862Q38903129-C0A1D5F4-3E6D-4515-A3A5-BECB27AB4F29Q39375417-F6B7AE0B-61A3-42AC-933E-23EC01089FC3Q50193268-1048AEF1-0723-40DA-AC12-E89B074A54DCQ55044654-488C2544-EEBF-4A3E-85E0-523268F860F3Q55163181-8D7C4097-5748-4EEF-9C58-2D1FC1EEC4C7
P2860
Therapeutic strategies in psoriasis patients with psoriatic arthritis: focus on new agents.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Therapeutic strategies in psor ...... rthritis: focus on new agents.
@en
type
label
Therapeutic strategies in psor ...... rthritis: focus on new agents.
@en
prefLabel
Therapeutic strategies in psor ...... rthritis: focus on new agents.
@en
P2093
P2860
P1433
P1476
Therapeutic strategies in psor ...... rthritis: focus on new agents.
@en
P2093
Emily Yiping Gan
Hong Liang Tey
Wei-Sheng Chong
P2860
P2888
P304
P356
10.1007/S40259-013-0025-6
P577
2013-08-01T00:00:00Z